A number of correlative studies utilizing invasive biopsy in conjunction with immunohistochemistry (IHC) suggest that PD-1 expression on tumor-infiltrating CD8+ T cells could serve as a predictive marker [21]. This evidence concerns the gene PDCD1 and neoplasm.